Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Enterprise Value (2016 - 2025)

Phibro Animal Health has reported Enterprise Value over the past 13 years, most recently at -$74.5 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$74.5 million for Q4 2025, down 11.08% from a year ago — trailing twelve months through Dec 2025 was -$74.5 million (down 11.08% YoY), and the annual figure for FY2025 was -$77.0 million, up 32.78%.
  • Enterprise Value for Q4 2025 was -$74.5 million at Phibro Animal Health, up from -$85.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for PAHC hit a ceiling of -$43.8 million in Q3 2021 and a floor of -$114.6 million in Q2 2024.
  • Median Enterprise Value over the past 5 years was -$88.1 million (2022), compared with a mean of -$84.7 million.
  • Biggest five-year swings in Enterprise Value: soared 52.37% in 2021 and later plummeted 96.95% in 2022.
  • Phibro Animal Health's Enterprise Value stood at -$95.5 million in 2021, then rose by 17.87% to -$78.4 million in 2022, then fell by 17.94% to -$92.5 million in 2023, then increased by 27.48% to -$67.1 million in 2024, then fell by 11.08% to -$74.5 million in 2025.
  • The last three reported values for Enterprise Value were -$74.5 million (Q4 2025), -$85.3 million (Q3 2025), and -$77.0 million (Q2 2025) per Business Quant data.